Related Experiment Video
Updated: May 8, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
[Gene disorders and molecular genetic subtypes of malignant gliomas]
Abstract:
Malignant brain tumors are noteworthy for a lot of genetic disorders that show itself as decreased or increased gene function of different genes and lead to tumor development. The differences in the molecular genetic profile can identify several subtypes of malignant gliomas, which are distinguished by both their clinical course and susceptibility to drugs. This can be the basis for developing individualized therapy options in patients with malignant gliomas.
Insights
Genetic disorders in malignant brain tumors drive tumor development. Molecular profiles reveal glioma subtypes, enabling personalized treatment strategies for better patient outcomes.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Context:
- Malignant brain tumors, particularly gliomas, are characterized by genetic alterations affecting gene function.
- These molecular variations contribute to tumor initiation and progression.
- Understanding these genetic underpinnings is crucial for advancing brain tumor research.
Purpose:
- To explore the role of genetic disorders in malignant brain tumor development.
- To investigate how molecular genetic profiles differentiate glioma subtypes.
- To establish a foundation for personalized therapeutic approaches in glioma patients.
Summary:
- Malignant brain tumors arise from genetic disorders causing altered gene function.
- Distinct molecular genetic profiles define various malignant glioma subtypes.
- These subtypes exhibit unique clinical behaviors and drug responses.
Impact:
- Molecular profiling facilitates the identification of specific glioma subtypes.
- This subtype classification aids in predicting clinical course and therapeutic susceptibility.
- It paves the way for developing individualized therapy options for malignant glioma patients.

